Key facts
- It has raised $28.1M; the latest was Later Stage VC ($10.3M) in Feb 2025.
- Notable investors include Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company), Holland Capital (Private Equity), Rotrip Europe, Curie Capital — 13 tracked in total.
- Status: Privately Held (backing).
Investors
13+- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Sirius Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Sirius Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sirius Medical
Developer of a tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.
- Sector
- Healthcare
- HQ
- Eindhoven, Netherlands
- Founded
- 2017
- Employees
- 50
- Website
- sirius-medical.com/
- Ownership
- Privately Held (backing)
Sirius Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sirius Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sirius Medical in its N-PORT filings yet. We sweep new filings monthly.